Heat shock protein 90 inhibition effective and safe option against Hidradenitis Suppurativa
In a recent clinical trial discovered promising outcomes of heat shock protein 90 inhibition by RGRN-305 for individuals suffering from moderate to severe Hidradenitis Suppurativa (HS), a painful immune-mediated disorder. This results were published in Journal of American Medical Association. The randomized clinical study was conducted from September 22, 2021, to August 29, 2022 at […]